Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes
- PMID: 23929934
- PMCID: PMC3806611
- DOI: 10.2337/db13-0215
Decreased cord-blood phospholipids in young age-at-onset type 1 diabetes
Abstract
Children developing type 1 diabetes may have risk markers already in their umbilical cord blood. It is hypothesized that the risk for type 1 diabetes at an early age may be increased by a pathogenic pregnancy and be reflected in altered cord-blood composition. This study used metabolomics to test if the cord-blood lipidome was affected in children diagnosed with type 1 diabetes before 8 years of age. The present case-control study of 76 index children diagnosed with type 1 diabetes before 8 years of age and 76 healthy control subjects matched for HLA risk, sex, and date of birth, as well as the mother's age and gestational age, revealed that cord-blood phosphatidylcholines and phosphatidylethanolamines were significantly decreased in children diagnosed with type 1 diabetes before 4 years of age. Reduced levels of triglycerides correlated to gestational age in index and control children and to age at diagnosis only in the index children. Finally, gestational infection during the first trimester was associated with lower cord-blood total lysophosphatidylcholines in index and control children. In conclusion, metabolomics of umbilical cord blood may identify children at increased risk for type 1 diabetes. Low phospholipid levels at birth may represent key mediators of the immune system and contribute to early induction of islet autoimmunity.
Figures
References
-
- DIAMOND Project Group Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857–866 - PubMed
-
- EURODIAB ACE Study Group Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000;355:873–876 - PubMed
-
- Eisenbarth GS. Prediction of type 1 diabetes: the natural history of the prediabetic period. Adv Exp Med Biol 2004;552:268–290 - PubMed
-
- La Torre D, Lernmark A. Immunology of beta-cell destruction. Adv Exp Med Biol 2010;654:537–583 - PubMed
-
- Törn C, Mueller PW, Schlosser M, Bonifacio E, Bingley PJ, Participating Laboratories Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2. Diabetologia 2008;51:846–852 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
